Viela Bio
Why Robinhood?
You can watch Viela Bio and buy or sell other stocks, ETFs, and their options commission-free!About VIE
Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The firms product candidate includes inebilizumab, which is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells; VIB4920, which is a fusion protein designed to bind to CD40L on activated T cells, blocking their interaction with CD40-expressing B cells and potentially other binding partners; and VIB7734, which is a humanized mAb intended to be a novel treatment for autoimmune diseases where the pathology is driven principally by overproduction of type I interferons and other cytokines secreted by pDCs.
VIE Key Statistics
Stock Snapshot
The current Viela Bio(VIE) stock price is $53.01, with a market capitalization of 2.91B. The stock trades at a price-to-earnings (P/E) ratio of -18.64.
On 2026-02-16, Viela Bio(VIE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Viela Bio(VIE) stock has reached 0, versus its average volume of 755.94K.
The stock's 52-week range extends from a low of $25.02 to a high of $65.00.
The stock's 52-week range extends from a low of $25.02 to a high of $65.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.